The results showed an elevated galectin-3 in all PAH patients.49 Although these findings were encouraging, galectin-3 lacks the specificity to serve as a sole biomarker, since elevated concentrations can also be detected in patients diagnosed with renal failure, pulmonary and hepatic fibrosis.50 This evidence concerns the gene LGALS3 and kidney failure.